News

BioStat® Research
& Development Centre

2024 2023 2022 older
Biostat 6th consecutive year as research and development center
18
October
2024
Biostat 6th consecutive year as research and development center
The Minister of Development and Technology has decided to maintain Biostat's status as a research and development...
Study on generalized myasthenia gravis for AstraZeneca
09
October
2024
Study on generalized myasthenia gravis for AstraZeneca
The Biostat Research and Development Center will carry out another project in collaboration with AstraZeneca. T...
Study of new solutions in surgery for Corza Medical
26
August
2024
Study of new solutions in surgery for Corza Medical
The Biostat Research and Development Center has signed an agreement with Corza Medical to conduct a PASS study in the...
Aneta Piechaczek, Phd from Biostat co-authors a wcientific article
21
August
2024
Aneta Piechaczek, Phd from Biostat co-authors a wcientific article
Marek Kluszczyński, MD, who specializes in the rehabilitation of children and adolescents, has published a scientific...
Biostat will conduct a medical experiment for Stallergenes Greer
17
July
2024
Biostat will conduct a medical experiment for Stallergenes Greer
Biostat Research and Development Center has signed an agreement with a pharmaceutical company Stallergenes Greer to c...
Cooperation of Biostat and Medinice. Doctors used the CoolCryo system during surgery
09
July
2024
Cooperation of Biostat and Medinice. Doctors used the CoolCryo system during surgery
The innovative CoolCryo® system for cardiac cryoablation, for which Biostat is conducting a clinical trial,...
Biostat will conduct a non-interventional study for Adamed Pharma
27
June
2024
Biostat will conduct a non-interventional study for Adamed Pharma
A non-interventional study among cardiology patients - this is a new field of cooperation between the Biostat R...
Biostat listed in the Forbes ranking
21
May
2024
Biostat listed in the Forbes ranking
For another year in a row, Biostat Research and Development Center has been recognized in the ranking of the most dyn...
Biostat and MSD Polska collaborate on lung cancer study
16
May
2024
Biostat and MSD Polska collaborate on lung cancer study
The Biostat Research and Development Centre starts cooperation with the MSD Polska pharmaceutical company. ...
Post-stroke aphasia. Biostat in a clinical trial in the US
15
February
2024
Post-stroke aphasia. Biostat in a clinical trial in the US
Biostat's Research and Development Center has prepared a randomization system for a clinical trial being conducte...
It's been a good year! Summary of 2023 at Biostat
12
February
2024
It's been a good year! Summary of 2023 at Biostat
It's been a good year! Summary of 2023 at Biostat We summarize 2023 at Biostat Group. We are p...
21
January
2019
eCRF.biz™ system conquers the Polish market
21
January
2019

eCRF.biz™ system conquers the Polish market

BioStat® is a brand not only known for statistics and analyses. Our company position has significantly changed in recent years thanks to eCRF.biz™ software, which revolutionised the world of clinical trials in the local market.

Our experience in carrying out clinical trials has confirmed our beliefs that the effectiveness of the research activities taken depends on the comprehensibility of the whole process. Being bold in thinking about the development of scientific projects has led us to the point of designing the tool that BioStat® can be now proud of.

The eCRF.biz™ system is a leading and constantly developing product of BioStat® allowing for global maintenance and keeping data organisation from clinical trials conducted all over the world with only one app. The level of innovations used can be definitely described as ground-breaking.

In the face of constantly changing the digital environment and formal requirements, we optimize the system and adjust it to the real needs of our Clients. The positive feedback from the Clients and recognition earned for the system creators reveals in an even more optimistic attitude towards reaching for superior effects.

We think that the time is ripe to make an intensive expansion abroad and soon we will have the opportunity to show up at several important events as well as in the media.

 

> Learn more about Biostat's clinical research services

See also
Study of new solutions in surgery for Corza Medical Study of new solutions in surgery for Corza Medical
The Biostat Research and Development Center has signed an agreement with Corza Medical to conduct a PASS study in the...
Biostat will conduct a medical experiment for Stallergenes Greer Biostat will conduct a medical experiment for Stallergenes Greer
Biostat Research and Development Center has signed an agreement with a pharmaceutical company Stallergenes Greer to c...
Cooperation of Biostat and Medinice. Doctors used the CoolCryo system during surgery Cooperation of Biostat and Medinice. Doctors used the CoolCryo system during surgery
The innovative CoolCryo® system for cardiac cryoablation, for which Biostat is conducting a clinical trial,...
Biostat will conduct a non-interventional study for Adamed Pharma Biostat will conduct a non-interventional study for Adamed Pharma
A non-interventional study among cardiology patients - this is a new field of cooperation between the Biostat R...
Copyright© 2023 Biostat